National Institute on Drug Abuse; Notice of Closed Meeting

Federal Register, Volume 85 Issue 102 (Wednesday, May 27, 2020)
[Federal Register Volume 85, Number 102 (Wednesday, May 27, 2020)]
[Page 31787]
From the Federal Register Online via the Government Publishing Office []
[FR Doc No: 2020-11275]
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
 The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
 Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Step Up for Substance Use Disorders (SUD): A Drug
Target Initiative for Scientists Engaged in Fundamental Research
(U18--Clinical Trial Not Allowed).
 Date: June 9, 2020.
 Time: 9:00 a.m. to 5:00 p.m.
 Agenda: To review and evaluate grant applications.
 Place: National Institutes of Health, Neurosciences Center
Building, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
 Contact Person: Trinh T. Tran, Scientific Research Officer,
Office of Extramural Policy and Review, Division of Extramural
Research, National Institute on Drug Abuse, NIH, 6001 Executive
Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, (301) 827-5843,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
 Dated: May 20, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-11275 Filed 5-26-20; 8:45 am]